Paper39939446
The Sirt1/FOXO signal pathway involves in regulating osteomyelitis progression via modulating mitochondrial dysfunctions and osteogenic differentiation.
Zhang R and 5 others. J Mol Histol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. The Sirt1/FOXO signal pathway involves in regulating osteomyelitis progression via modulating mitochondrial dysfunctions and osteogenic differentiation. Papers, record 39939446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39939446
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Sirt1/FOXO signal pathway involves in regulating osteomyelitis progression via modulating mitochondrial dysfunctions and osteogenic differentiation.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sirtuin 1 | Major topic |
| Osteogenesis | Major topic |
| Signal Transduction | Major topic |
| Cell Differentiation | Major topic |
| Mitochondria | Major topic |
| Osteomyelitis | Major topic |
| Forkhead Transcription Factors | Major topic |
| Animals | |
| Mice | |
| Disease Progression | |
| RAW 264.7 Cells | |
| Osteoblasts | |
| Cell Line | |
| Forkhead Box Protein O1 |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 202101AO070314 | the special basic cooperative research programs of Yunnan provincial undergraduate universities | PubMed | ||
| 82460432 | the Regional Science Foundation Project of the National Natural Science Foundation of China | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 40278934 | Correction: The Sirt1/FOXO signal pathway involves in regulating osteomyelitis progression via modulating mitochondrial dysfunctions and osteogenic differentiation. | https://conductscience.org/library/papers/40278934 |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34023442 | Quercetin-mediated SIRT1 activation attenuates collagen-induced mice arthritis. | J Ethnopharmacol | 2021 | https://conductscience.org/library/papers/34023442 | PubMed |
| 2 | 34652112 | Osteomyelitis: Diagnosis and Treatment. | Am Fam Physician | 2021 | https://conductscience.org/library/papers/34652112 | PubMed |
| 3 | 32967533 | Mitophagy in degenerative joint diseases. | Autophagy | 2021 | https://conductscience.org/library/papers/32967533 | PubMed |
| 4 | 27607236 | Silencing of Long Non-Coding RNA NONHSAT009968 Ameliorates the Staphylococcal Protein A-Inhibited Osteogenic Differentiation in Human Bone Mesenchymal Stem Cells. | Cell Physiol Biochem | 2016 | https://conductscience.org/library/papers/27607236 | PubMed |
| 5 | 35907249 | p300 arrests intervertebral disc degeneration by regulating the FOXO3/Sirt1/Wnt/β-catenin axis. | Aging Cell | 2022 | https://conductscience.org/library/papers/35907249 | PubMed |
| 6 | 34364937 | A review study on the modulation of SIRT1 expression by miRNAs in aging and age-associated diseases. | Int J Biol Macromol | 2021 | https://conductscience.org/library/papers/34364937 | PubMed |
| 7 | 31006177 | Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1. | FEBS Open Bio | 2019 | https://conductscience.org/library/papers/31006177 | PubMed |
| 8 | 33065089 | Long noncoding RNA MIAT regulates primary human retinal pericyte pyroptosis by modulating miR-342-3p targeting of CASP1 in diabetic retinopathy. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/33065089 | PubMed |
| 9 | 37370094 | Identification of molecular subgroups in osteomyelitis induced by staphylococcus aureus infection through gene expression profiles. | BMC Med Genomics | 2023 | https://conductscience.org/library/papers/37370094 | PubMed |
| 10 | 28937996 | SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. | PLoS One | 2017 | https://conductscience.org/library/papers/28937996 | PubMed |
| 11 | 32096765 | PKM2 suppresses osteogenesis and facilitates adipogenesis by regulating β-catenin signaling and mitochondrial fusion and fission. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32096765 | PubMed |
| 12 | 36982790 | Ultrastructural Evidence of Mitochondrial Dysfunction in Osteomyelitis Patients. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982790 | PubMed |
| 13 | 31154010 | Mitochondria as playmakers of apoptosis, autophagy and senescence. | Semin Cell Dev Biol | 2020 | https://conductscience.org/library/papers/31154010 | PubMed |
| 14 | 31788976 | Dexamethasone promotes mesenchymal stem cell apoptosis and inhibits osteogenesis by disrupting mitochondrial dynamics. | FEBS Open Bio | 2020 | https://conductscience.org/library/papers/31788976 | PubMed |
| 15 | 31721069 | Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis. | Curr Osteoporos Rep | 2019 | https://conductscience.org/library/papers/31721069 | PubMed |
| 16 | 29624568 | Resveratrol Attenuates Lipopolysaccharides (LPS)-Induced Inhibition of Osteoblast Differentiation in MC3T3-E1 Cells. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/29624568 | PubMed |
| 17 | 38264287 | Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/38264287 | PubMed |
| 18 | 35879417 | Mitochondrial control of inflammation. | Nat Rev Immunol | 2023 | https://conductscience.org/library/papers/35879417 | PubMed |
| 19 | 35562962 | Structural Analysis of Mitochondrial Dynamics-From Cardiomyocytes to Osteoblasts: A Critical Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35562962 | PubMed |
| 20 | 33453243 | SIRT1, a promising regulator of bone homeostasis. | Life Sci | 2021 | https://conductscience.org/library/papers/33453243 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40427485 | New Perspectives on Postmenopausal Osteoporosis: Mechanisms and Potential Therapeutic Strategies of Sirtuins and Oxidative Stress. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40427485 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39939446
GET https://conductscience.org/api/papers/v1/39939446/references?page=2